言語を選択

SLC6A2

お問い合わせ

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
RC-88	RC-88	Phase 2 Clinical	RemeGen Co Ltd	Solid tumours; Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Fallopian Tube Neoplasms	詳細
iCasp9M28z	iCasp9M28z	Phase 2 Clinical	Memorial Sloan Kettering Cancer Center	Small Cell Lung Carcinoma; Pleural Diseases; Mesothelioma; Breast Neoplasms; Lung Neoplasms; Neoplasm Metastasis	詳細
Anetumab ravtansine	BAY-94-9343; BAY-94-9343-SPDB-DM4; Anti-mesothelin antibody-drug conjugate BAY 94-9343	Phase 2 Clinical	Bayer AG	Solid tumours; Ovarian Neoplasms; Cystadenocarcinoma, Serous; Neoplasms; Pancreatic Neoplasms; Mesothelioma; Peritoneal Neoplasms; Lung Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid	詳細
Gavocabtagene autoleucel	TC-210	Phase 2 Clinical	Tcr2 Therapeutics Inc	Ovarian Neoplasms; Mesothelioma; Cholangiocarcinoma; Carcinoma, Non-Small-Cell Lung	詳細
LMB-100	LMB-100; RG-7787; RO-6927005	Phase 2 Clinical	F. Hoffmann-La Roche Ltd	Neoplasms, Mesothelial; Carcinoma; Small Cell Lung Carcinoma; Adenocarcinoma of Lung; Neoplasms; Pancreatic Neoplasms; Mesothelioma; Cholangiocarcinoma; Lung Neoplasms; Pleural Effusion, Malignant; Carcinoma, Non-Small-Cell Lung	詳細
anti-MESO CAR-T cells (Zhejiang University)	UCLM802; UCLM-802	Phase 2 Clinical	Zhejiang University, Hrain Biotechnology Co Ltd	Ovarian Neoplasms; Solid tumours	詳細
Anti-CTLA-4 and PD-1 CAR-T cell therapy (Shanghai Cell Therapy Research Institute)		Phase 2 Clinical	Shanghai Cell Therapy Research Institute	Neoplasms	詳細
HPN-536	HPN-536	Phase 2 Clinical	Harpoon Therapeutics	Neoplasms	詳細
Autologous PD-1 antibody expressing mesothelin-targeted CAR-Tcells therapy (Shanghai Cell Therapy Research Institute)		Phase 2 Clinical	Shanghai Cell Therapy Research Institute	Solid tumours	詳細
CD40 ligand expressing MSLN-CAR T cells		Phase 2 Clinical	Pla General Hospital	Solid tumours	詳細
A2B-694	A2B-694; A2B694	Phase 2 Clinical	A2 Biotherapeutics Inc	Solid tumours; Ovarian Neoplasms; Rectal Neoplasms; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Colonic Neoplasms; Pancreatic Neoplasms; Neoplasms; Mesothelioma; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung	詳細
RNA-Meso-CIR-T	RNA-Meso-CIR-T	Phase 1 Clinical	Novartis Pharma Ag, University Of Pennsylvania	Mesothelioma	詳細
CART-meso	CART-meso	Phase 1 Clinical	Novartis Pharma Ag, University Of Pennsylvania	Ovarian Neoplasms; Carcinoma; Adenocarcinoma of Lung; Carcinoma, Ovarian Epithelial; Pancreatic Neoplasms; Mesothelioma; Breast Neoplasms; Fallopian Tube Neoplasms	詳細
ABBV-428	ABBV-428; ABBV428	Phase 1 Clinical	Abbvie Inc	Solid tumours	詳細
Anti-mesothelin thorium-227 labeled antibody chelator conjugate	BAY-2287411	Phase 1 Clinical	Bayer AG	Ovarian Neoplasms; Mesothelioma; Carcinoma, Pancreatic Ductal	詳細
AB-1015	AB-1015	Phase 1 Clinical	Arsenal Biosciences Inc	Ovarian Neoplasms; Carcinoma, Ovarian Epithelial	詳細
SynKIR-110	SynKIR™-110; SynKIR-meso	Phase 1 Clinical	Verismo Therapeutics Inc	Ovarian Neoplasms; Mesothelioma; Cholangiocarcinoma	詳細
KT-032	KT-032	Phase 1 Clinical	Nanjing Kati Medical Technology Co Ltd	Ovarian Neoplasms; Solid tumours; Pancreatic Neoplasms; Mesothelioma	詳細
JNJ-79032421	JNJ-79032421; JNJ-2421	Phase 1 Clinical	Janssen Research & Development Llc	Solid tumours	詳細
YL-215	YL215; YL-215	Phase 1 Clinical	MediLink Therapeutics Co Ltd	Solid tumours	詳細
GPC3/Mesothelin-CAR-γδT Cells therapy(Second Affiliated Hospital Of Guangzhou Medical University)		Phase 1 Clinical	Second Affiliated Hospital Of Guangzhou Medical University	Solid tumours; Liver Neoplasms; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Mesothelioma; Lung Neoplasms	詳細
AMG 305	AMG-305; AMG 305	Phase 1 Clinical	Amgen Inc	Solid tumours	詳細
Mesothelin-CAR-T Cells (Fapon Biopharma)		Phase 1 Clinical	Fapon Biotech Inc	Pancreatic Neoplasms	詳細
UCMYM-802	UCMYM802; UCMYM-802	Phase 1 Clinical	Shanghai Youti zjisheng Biomedicine Co Ltd	Solid tumours; Ovarian Neoplasms; Rectal Neoplasms; Pancreatic Neoplasms; Mesothelioma; Breast Neoplasms; Colorectal Neoplasms; Bile Duct Neoplasms	詳細
HBM-9033	HBM-9033; HBM9033	Phase 1 Clinical	Nona Biosciences	Solid tumours	詳細
Anti-mesothelin CAR T cell therapy (UTC Therapeutics Inc)		Phase 1 Clinical	UTC Therapeutics Inc	Solid tumours	詳細
ZW-171	ZW-171	Phase 1 Clinical	Zymeworks Inc	Solid tumours; Neoplasms	詳細
LD013 CAR T-cell therapy (Nanjing Landun Biotechnology)	LD013; LD-013	Phase 1 Clinical	Nanjing Landun Biotechnology Co Ltd	Ovarian Neoplasms; Solid tumours	詳細
RD-138	RD-138	Phase 1 Clinical	Nanjing Iaso Biotherapeutics Co Ltd	Multiple Myeloma	詳細
RD-133	RD133	Phase 1 Clinical	Nanjing Iaso Biotherapeutics Co Ltd	Solid tumours; Neoplasms	詳細
PM-3006	PM-3006	Phase 1 Clinical	Biotheus Inc		詳細
Autologous Mesothelin-specific TCR-T Cell Therapy (Lonza Walkersville)		Phase 1 Clinical	Fred Hutchinson Cancer Research Center	Pancreatic Neoplasms; Carcinoma, Pancreatic Ductal	詳細
Anti-mesothelin CAR-NK cell therapy(Guojianchengnuo)	ALF-101	Phase 1 Clinical	Guojianchengnuo Biotechnology (Beijing) Co Ltd	Carcinoma, Ovarian Epithelial	詳細
Inezetamab	AMG-994	Phase 1 Clinical	Amgen Inc	Solid tumours	詳細
αPD1-MSLN-CAR T cell therapy (Shanghai Cell Therapy Group Co.,Ltd)	BZDS1901; BZDS-1901; BZD1901	Phase 1 Clinical		Ovarian Neoplasms; Solid tumours; Mesothelioma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung	詳細
KD-021	KD-021	Phase 1 Clinical	Nanjing Kaedi Biotechnology Co Ltd	Neoplasms	詳細
Anti-mesothelin CAR-T (Pregene)		Clinical	Pregene (Shenzhen) Biotechnology Co Ltd	Hydrothorax	詳細
TCR-like CAR-T Cell Therapy(Zhongda Hospital Southeast University)			Zhongda Hospital Southeast University		詳細